Picture of BioXcel Therapeutics logo

BTAIQ — BioXcel Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Bioxcel Therapeutics Announces Termination Of Proposed Public Offering

Feb 13 (Reuters) - BioXcel Therapeutics Inc  BTAI.O :
    * BIOXCEL THERAPEUTICS ANNOUNCES TERMINATION OF PROPOSED
PUBLIC
OFFERING
    * TERMINATED ITS PROPOSED PUBLIC OFFERING OF $60.0 MILLION
OF
SHARES OF ITS COMMON STOCK
    * CURRENT MARKET CONDITIONS ARE NOT CONDUCIVE FOR AN
OFFERING ON
TERMS THAT WOULD BE IN BEST INTERESTS OF STOCKHOLDERS
    * INTENDS TO FOCUS ON ITS UPCOMING MEETING WITH FDA ON FEB
20, FOR
ITS PHASE 3 TRANQUILITY AT HOME TRIAL

Source text for Eikon:  ID:nGNX2539L2 
Further company coverage:  BTAI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BioXcel Therapeutics

See all news